Exploring racial and diagnostic differences in motor performance along the Alzheimer's disease continuum: Insights from the ARMADA study

Abstract

Background: Motor impairments are emerging predictors of amnestic mild cognitive impairment (aMCI) and dementia of the Alzheimer's type (DAT), with these groups demonstrating worse performance on metrics such as gait speed and endurance relative to cognitively normal (NC) controls (Windham et al., 2022).